MedTrace Logo

Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease

NCT00641524 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2016-05-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate the use of phlebotomy (blood taking)as a treatment for patients with non-alcoholic fatty liver disease.

Conditions

  • Non-alcoholic Fatty Liver Disease

Interventions

PROCEDURE

Phlebotomy

Phlebotomy involves the removal of blood (approximately 500mL) each week until body iron levels reach the low-normal level

Sponsors & Collaborators

  • University of Western Ontario, Canada

    lead OTHER

Principal Investigators

  • Melanie D Beaton, MD · Western University, Canada

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00641524 on ClinicalTrials.gov